INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.870
+0.040 (2.19%)
At close: Oct 14, 2025, 4:00 PM EDT
1.860
-0.010 (-0.52%)
After-hours: Oct 14, 2025, 6:09 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
INKmune and DN-TNF Product Platform
14.00K
Log In
Log In
Log In
Log In
INKmune and DN-TNF Product Platform Growth
-90.97%
Log In
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
14.00K
Log In
Log In
Log In
Log In
United States Growth
-90.97%
Log In
Log In
Log In
Log In